|
|
Volumn 15, Issue 9, 2001, Pages 1193-1194
|
|
Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
EFAVIRENZ;
BODY MASS;
BODY WEIGHT;
DRUG BLOOD LEVEL;
DRUG MONITORING;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
MEDICAL RESEARCH;
METHODOLOGY;
NEUROTOXICITY;
PATIENT COMPLIANCE;
PRIORITY JOURNAL;
STATISTICAL ANALYSIS;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
|
EID: 0035875828
PISSN: 02699370
EISSN: None
Source Type: Journal
DOI: 10.1097/00002030-200106150-00023 Document Type: Letter |
|
Times cited : (300)
|
|
References (1)
|
